A metric and workflow for quality control in the analysis of heterogeneity in phenotypic profiles and screens

被引:9
作者
Gough, Albert [1 ,2 ]
Shun, Tong Ying [1 ]
Taylor, D. Lansing [1 ,2 ]
Schurdak, Mark [1 ,2 ]
机构
[1] Univ Pittsburgh, Drug Discovery Inst, 3501 Fifth Ave,BST3 10052, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Computat & Syst Biol, 3501 Fifth Ave, Pittsburgh, PA USA
关键词
Heterogeneity; Phenotypic profiling; High content screening; Systems biology; Drug discovery; KOLMOGOROV-SMIRNOV TEST; TUMOR HETEROGENEITY; CELL VARIABILITY; ORIGINS; BIOLOGY; ERA; MICROENVIRONMENT; ESTABLISHMENT; MICROSCOPY; DISCOVERY;
D O I
10.1016/j.ymeth.2015.10.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Heterogeneity is well recognized as a common property of cellular systems that impacts biomedical research and the development of therapeutics and diagnostics. Several studies have shown that analysis of heterogeneity: gives insight into mechanisms of action of perturbagens; can be used to predict optimal combination therapies; and can be applied to tumors where heterogeneity is believed to be associated with adaptation and resistance. Cytometry methods including high content screening (HCS), high throughput microscopy, flow cytometry, mass spec imaging and digital pathology capture cell level data for populations of cells. However it is often assumed that the population response is normally distributed and therefore that the average adequately describes the results. A deeper understanding of the results of the measurements and more effective comparison of perturbagen effects requires analysis that takes into account the distribution of the measurements, i.e. the heterogeneity. However, the reproducibility of heterogeneous data collected on different days, and in different plates/slides has not previously been evaluated. Here we show that conventional assay quality metrics alone are not adequate for quality control of the heterogeneity in the data. To address this need, we demonstrate the use of the KolmogorovSmirnov statistic as a metric for monitoring the reproducibility of heterogeneity in an SAR screen, describe a workflow for quality control in heterogeneity analysis. One major challenge in high throughput biology is the evaluation and interpretation of heterogeneity in thousands of samples, such as compounds in a cell-based screen. In this study we also demonstrate that three heterogeneity indices previously reported, capture the shapes of the distributions and provide a means to filter and browse big data sets of cellular distributions in order to compare and identify distributions of interest. These metrics and methods are presented as a workflow for analysis of heterogeneity in large scale biology projects. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:12 / 26
页数:15
相关论文
共 39 条
  • [21] Quantitation of multiclonality in control and drug-treated tumour populations using high-throughput analysis of karyotypic heterogeneity
    Dayal, Jasbani H. S.
    Albergante, Luca
    Newman, Timothy J.
    South, Andrew P.
    CONVERGENT SCIENCE PHYSICAL ONCOLOGY, 2015, 1 (02):
  • [22] Clinical and neurocognitive profiles of a combined clinical high risk for psychosis and clinical control sample: latent class analysis
    Stuble, Miriam
    Schultze-Lutter, Frauke
    Kaess, Michael
    Franscini, Maurizia
    Traber-Walker, Nina
    Walger, Petra
    Schimmelmann, Benno G.
    Vogeley, Kai
    Kambeitz, Joseph
    Kindler, Jochen
    Michel, Chantal
    BJPSYCH OPEN, 2024, 10 (06):
  • [23] A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis
    Wu, Zijie
    Dong, Zehua
    Luo, Jiangti
    Hu, Weiwei
    Tong, Yue
    Gao, Xiangdong
    Yao, Wenbing
    Tian, Hong
    Wang, Xiaosheng
    GENOMICS, 2024, 116 (03)
  • [24] Comprehensive analysis of the RNA transcriptome expression profiles and construction of the ceRNA network in heart failure patients with sacubitril/valsartan therapeutic heterogeneity after acute myocardial infarction
    Su, Jia
    Hu, Yingchu
    Cheng, Ji
    Li, Zhenwei
    Li, Jiyi
    Zheng, Nan
    Zhang, Zhaoxia
    Yang, Jin
    Li, Xiaojin
    Yu, Qinglin
    Du, Weiping
    Chen, Xiaomin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 944
  • [25] Rapid quantitative analysis of Chinese Gu-Jing-Gong spirit for its quality control
    Zhang, Zheng-Yong
    Sha, Min
    Liu, Jun
    Wang, Hai-Yan
    JOURNAL OF THE INSTITUTE OF BREWING, 2017, 123 (03) : 464 - 467
  • [26] A novel real-time cell electronic analysis technology for the authentication and quality control of natural medicines
    Yan, Guo-Jun
    Mei, Xin
    Yang, Jin
    Zhu, Jenny
    Wu, Jie-Ying
    Pan, Jin-Huo
    CHINESE CHEMICAL LETTERS, 2013, 24 (12) : 1140 - 1144
  • [27] Features that best define the heterogeneity and homogeneity of autism in preschool-age children: A multisite case-control analysis replicated across two independent samples
    Wiggins, Lisa D.
    Tian, Lin H.
    Rubenstein, Eric
    Schieve, Laura
    Daniels, Julie
    Pazol, Karen
    DiGuiseppi, Carolyn
    Barger, Brian
    Moody, Eric
    Rosenberg, Steven
    Bradley, Chyrise
    Hsu, Melanie
    Rosenberg, Cordelia Robinson
    Christensen, Deborah
    Crume, Tessa
    Pandey, Juhi
    Levy, Susan E.
    AUTISM RESEARCH, 2022, 15 (03) : 539 - 550
  • [28] Dr. seq2: A quality control and analysis pipeline for parallel single cell transcriptome and epigenome data
    Zhao, Chengchen
    Hu, Sheng'en
    Huo, Xiao
    Zhang, Yong
    PLOS ONE, 2017, 12 (07):
  • [29] Economic Evaluation of Quality Improvement Interventions Designed to Improve Glycemic Control in Diabetes: A Systematic Review and Weighted Regression Analysis
    Nuckols, Teryl K.
    Keeler, Emmett
    Anderson, Laura J.
    Green, Jonas
    Morton, Sally C.
    Doyle, Brian J.
    Shetty, Kanaka
    Arifkhanova, Aziza
    Booth, Marika
    Shanman, Roberta
    Shekelle, Paul
    DIABETES CARE, 2018, 41 (05) : 985 - 993
  • [30] Heterogeneity in resilience patterns and its prediction of 1-year quality of life outcomes among patients with newly diagnosed cancer: An exploratory piecewise growth mixture model analysis
    Liang, Mu Zi
    Liu, Mei Ling
    Tang, Ying
    Molassiotis, Alex
    Knobf, M. Tish
    Chen, Peng
    Hu, Guang Yun
    Sun, Zhe
    Yu, Yuan Liang
    Ye, Zeng Jie
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2023, 66